LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 100

Search options

  1. Article ; Online: The 2022 ACR vaccination guideline: a call-to-action.

    Colmegna, Inés / Libman, Michael

    Nature reviews. Rheumatology

    2023  Volume 19, Issue 5, Page(s) 263–264

    Language English
    Publishing date 2023-03-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2491532-4
    ISSN 1759-4804 ; 1759-4790
    ISSN (online) 1759-4804
    ISSN 1759-4790
    DOI 10.1038/s41584-023-00954-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort.

    Colmegna, Ines / Weinblatt, Michael E

    The Journal of rheumatology

    2022  Volume 49, Issue 10, Page(s) 1077–1078

    MeSH term(s) Humans ; Pandemics ; Canada/epidemiology
    Language English
    Publishing date 2022-09-01
    Publishing country Canada
    Document type Editorial ; Comment
    ZDB-ID 194928-7
    ISSN 1499-2752 ; 0315-162X
    ISSN (online) 1499-2752
    ISSN 0315-162X
    DOI 10.3899/jrheum.220811
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: MSC - targets for atherosclerosis therapy.

    Colmegna, Ines / Stochaj, Ursula

    Aging

    2018  Volume 11, Issue 2, Page(s) 285–286

    MeSH term(s) Aging ; Atherosclerosis/drug therapy ; Humans ; Inflammation ; Mesenchymal Stem Cells/drug effects ; Risk Factors
    Language English
    Publishing date 2018-12-27
    Publishing country United States
    Document type Editorial
    ISSN 1945-4589
    ISSN (online) 1945-4589
    DOI 10.18632/aging.101735
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.

    Morozan, Arina / Joy, Sydney / Fujii, Utako / Fraser, Richard / Watters, Kevin / Martin, James G / Colmegna, Inés

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 20577

    Abstract: Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, immune dysregulation, and multi-organ fibrosis. Interstitial lung disease (ILD) is a complication of SSc and a leading cause of SSc-death. The administration of hypochlorous ...

    Abstract Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, immune dysregulation, and multi-organ fibrosis. Interstitial lung disease (ILD) is a complication of SSc and a leading cause of SSc-death. The administration of hypochlorous acid (HOCl) intradermally in the mouse (HOCl-SSc) purportedly shows several features typical of SSc. We studied the model by injecting BALB/c mice daily intradermally with HOCl for 6-weeks, an exposure reported to induce lung fibrosis. On day 42, the skinfold thickness and the dermal thickness were two and three times larger respectively in the HOCl group compared to controls. HOCl treatment did not result in histological features of pulmonary fibrosis nor significant changes in lung compliance. Automated image analysis of HOCl mice lungs stained with picrosirius red did not show increased collagen deposition. HOCl injections did not increase pulmonary mRNA expression of pro-fibrotic genes nor induced the production of serum advanced oxidation protein products and anti-topoisomerase 1 antibodies. Immune cells in bronchoalveolar lavage fluid (BALF) and whole lung digests were not increased in HOCl-treated animals. Since lung fibrosis is proposed to be triggered by oxidative stress, we injected HOCl to Nrf2
    MeSH term(s) Animals ; Mice ; Pulmonary Fibrosis/metabolism ; Hypochlorous Acid/metabolism ; Bleomycin/adverse effects ; Bleomycin/metabolism ; NF-E2-Related Factor 2/metabolism ; Skin/metabolism ; Fibrosis ; Lung Diseases, Interstitial/pathology ; Scleroderma, Systemic/pathology ; Lung/pathology ; Disease Models, Animal
    Chemical Substances Hypochlorous Acid (712K4CDC10) ; Bleomycin (11056-06-7) ; NF-E2-Related Factor 2
    Language English
    Publishing date 2023-11-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-47083-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Brodie abscess.

    Qi, Ruyu / Colmegna, Inés

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

    2017  Volume 189, Issue 3, Page(s) E117

    MeSH term(s) Abscess/diagnostic imaging ; Abscess/microbiology ; Abscess/therapy ; Adult ; Humans ; Male ; Osteomyelitis/diagnostic imaging ; Osteomyelitis/microbiology ; Osteomyelitis/therapy ; Staphylococcal Infections/complications ; Staphylococcal Infections/diagnosis ; Staphylococcal Infections/therapy
    Language English
    Publishing date 2017--23
    Publishing country Canada
    Document type Case Reports ; Journal Article
    ZDB-ID 215506-0
    ISSN 1488-2329 ; 0008-4409 ; 0820-3946
    ISSN (online) 1488-2329
    ISSN 0008-4409 ; 0820-3946
    DOI 10.1503/cmaj.151419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.

    Nadeau, Stéphanie / Cheng, Anastasia / Colmegna, Inés / Rodier, Francis

    Methods in molecular biology (Clifton, N.J.)

    2019  Volume 2045, Page(s) 93–105

    Abstract: Cellular senescence is a tumor suppressor mechanism that removes potentially neoplastic cells from the proliferative pool. Senescent cells naturally accumulate with advancing age; however, excessive/aberrant accumulation of senescent cells can disrupt ... ...

    Abstract Cellular senescence is a tumor suppressor mechanism that removes potentially neoplastic cells from the proliferative pool. Senescent cells naturally accumulate with advancing age; however, excessive/aberrant accumulation of senescent cells can disrupt normal tissue function. Multipotent mesenchymal stromal cells (MSCs), which are actively evaluated as cell-based therapy, can undergo replicative senescence or stress-induced premature senescence. The molecular characterization of MSCs senescence can be useful not only for understanding the clinical correlations between MSCs biology and human age or age-related diseases but also for identifying competent MSCs for therapeutic applications. Because MSCs are involved in regulating the hematopoietic stem cell niche, and MSCs dysfunction has been implicated in age-related diseases, the identification and selective removal of senescent MSC may represent a potential therapeutic target. Cellular senescence is generally defined by senescence-associated (SA) permanent proliferation arrest (SAPA) accompanied by persistent DNA damage response (DDR) signaling emanating from persistent DNA lesions including damaged telomeres. Alongside SA cell cycle arrest and DDR signaling, a plethora of phenotypic hallmarks help define the overall senescent phenotype including a potent SA secretory phenotype (SASP) with many microenvironmental functions. Due to the complexity of the senescence phenotype, no single hallmark is alone capable of identifying senescent MSCs. This protocol highlights strategies to validate MSCs senescence through the measurements of several key SA hallmarks including lysosomal SA Beta-galactosidase activity (SA-βgal), cell cycle arrest, persistent DDR signaling, and the inflammatory SASP.
    MeSH term(s) Cell Cycle Checkpoints/genetics ; Cell Cycle Checkpoints/physiology ; Cell Differentiation/genetics ; Cell Differentiation/physiology ; Cell Proliferation/genetics ; Cell Proliferation/physiology ; Cells, Cultured ; Cellular Senescence/genetics ; Cellular Senescence/physiology ; Cytokines/metabolism ; DNA Damage ; Deoxyuridine/analogs & derivatives ; Deoxyuridine/metabolism ; Enzyme-Linked Immunosorbent Assay ; Fluorescent Antibody Technique ; Humans ; Inflammation/metabolism ; Mesenchymal Stem Cells/enzymology ; Mesenchymal Stem Cells/metabolism ; Mesenchymal Stem Cells/physiology ; Mesenchymal Stem Cells/radiation effects ; Multipotent Stem Cells/enzymology ; Multipotent Stem Cells/metabolism ; Multipotent Stem Cells/physiology ; Multipotent Stem Cells/radiation effects ; Phenotype ; Signal Transduction/genetics ; Telomere/genetics ; Telomere/metabolism ; Workflow ; beta-Galactosidase/metabolism
    Chemical Substances Cytokines ; beta-Galactosidase (EC 3.2.1.23) ; 5-ethynyl-2'-deoxyuridine (G373S00W2J) ; Deoxyuridine (W78I7AY22C)
    Language English
    Publishing date 2019-04-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/7651_2019_217
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sunlight Exposure, Sun-Protective Behavior, and Anti-Citrullinated Protein Antibody Positivity: A General Population-Based Study in Quebec, Canada.

    Zhao, Naizhuo / Smargiassi, Audrey / Colmegna, Ines / Hudson, Marie / Fritzler, Marvin / Bernatsky, Sasha

    Arthritis care & research

    2021  Volume 74, Issue 2, Page(s) 236–242

    Abstract: Objective: To examine associations between sunlight exposure and anti-citrullinated protein antibodies (ACPAs) using general population data in Quebec, Canada.: Methods: A random sample of 7,600 individuals (including 786 subjects who were ACPA ... ...

    Abstract Objective: To examine associations between sunlight exposure and anti-citrullinated protein antibodies (ACPAs) using general population data in Quebec, Canada.
    Methods: A random sample of 7,600 individuals (including 786 subjects who were ACPA positive and 201 self-reported rheumatoid arthritis [RA] cases) from the CARTaGENE cohort was studied cross-sectionally. All subjects were nested in 4 census metropolitan areas, and mixed-effects logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) for ACPA positivity related to sunlight exposure, adjusting for sun-block use, industrial fine particulate matter (PM
    Results: The adjusted ORs and 95% CIs did not suggest conclusive associations between ACPA and sunlight exposure or sun-block use, but robust positive relationships were observed between industrial PM
    Conclusion: We did not see clear links between ACPA and sunlight exposure or sun-block use, but we did note positive associations with industrial PM
    MeSH term(s) Anti-Citrullinated Protein Antibodies ; Arthritis, Rheumatoid/immunology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Quebec ; Sunlight
    Chemical Substances Anti-Citrullinated Protein Antibodies
    Language English
    Publishing date 2021-12-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 645059-3
    ISSN 2151-4658 ; 0893-7524 ; 2151-464X
    ISSN (online) 2151-4658
    ISSN 0893-7524 ; 2151-464X
    DOI 10.1002/acr.24448
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis.

    Mendel, Arielle / Colmegna, Ines / Bourque, Guillaume / Rajda, Ewa / Lee, Todd C / Gálvez, José Héctor / Vinet, Évelyne / Cheng, Matthew P

    Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

    2022  Volume 7, Issue 2, Page(s) 131–134

    Abstract: Background: Few reports exist on the characteristics and outcomes of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised hosts.: Methods: A 49-year-old patient with granulomatosis with polyangiitis ( ... ...

    Abstract Background: Few reports exist on the characteristics and outcomes of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised hosts.
    Methods: A 49-year-old patient with granulomatosis with polyangiitis (GPA) and a renal transplant experienced multiple hospitalizations for coronavirus disease 2019 (COVID-19) pneumonia and relapses between October 2020 and February 2021. Careful chart review of medical history, hospitalizations, and microbiological testing including SARS-CoV-2 cycle threshold values, therapies, and imaging was undertaken. SARS-CoV-2 genome sequencing was performed in five viral samples to distinguish persistent infection from re-infection with a different strain.
    Results: Sequencing confirmed that all samples tested were from the same viral lineage, indicating a long-term, persistent infection rather than re-infection with a new strain. The patient ultimately stabilized after two courses of remdesivir plus dexamethasone, replacement intravenous immunoglobulin, and bamlanivimab. Rituximab maintenance therapy for vasculitis remains on hold.
    Conclusions: SARS-CoV-2 may persist for several months in immunocompromised hosts and may go unrecognized as an ongoing active infection. More studies are needed to determine how to optimize COVID-19 treatment in this vulnerable population.
    Language English
    Publishing date 2022-06-03
    Publishing country Canada
    Document type Journal Article
    ISSN 2371-0888
    ISSN (online) 2371-0888
    DOI 10.3138/jammi-2021-0033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells.

    Psaroudis, Rose Triantafillia / Singh, Urvashi / Lora, Maximilien / Jeon, Peter / Boursiquot, Abigail / Stochaj, Ursula / Langlais, David / Colmegna, Inés

    Stem cell research & therapy

    2022  Volume 13, Issue 1, Page(s) 358

    Abstract: Introduction: Human mesenchymal stromal cells (MSCs) have immunomodulatory, anti-inflammatory, and tolerogenic effects. Long-term in vitro expansion of MSCs to generate clinical grade products results in the accumulation of senescent-functionally ... ...

    Abstract Introduction: Human mesenchymal stromal cells (MSCs) have immunomodulatory, anti-inflammatory, and tolerogenic effects. Long-term in vitro expansion of MSCs to generate clinical grade products results in the accumulation of senescent-functionally impaired MSCs. Markers to assess the 'senescent load' of MSC products are needed.
    Methods: Early and late passage human adipose tissue (AT) MSCs from pediatric and adult donors were characterized using established senescent markers [i.e., MSC size, granularity, and autofluorescence by flow cytometry; β-galactosidase staining (SA-β-gal); CDKN2A and CDKN1A by qRT-PCR]. In gene set enrichment analysis, DPP4 (also known as adenosine deaminase complexing protein 2 or CD26) was found as a prominent dysregulated transcript that was increased in late passage MSC(AT). This was confirmed in a larger number of MSC samples by PCR, flow cytometry, Western blotting, and immunofluorescence. In vitro immunopotency assays compared the function of CD26
    Results: Late passage MSC(AT) had a senescence transcriptome signature. DPP4 was the most differentially enriched gene in senescent MSCs. Late passage senescent MSC(AT) had higher CD26 surface levels and total protein abundance. Moreover, CD26 surface levels were higher in early passage MSC(AT) from adults compared to pediatric donors. CD26 abundance correlated with established senescence markers. CD26
    Conclusions: DPP4 gene expression and DPP4/CD26 protein abundance are markers of replicative senescence in MSC(AT). Samples enriched in CD26
    MeSH term(s) Adipose Tissue/metabolism ; Adult ; Biomarkers/metabolism ; Cell Proliferation/genetics ; Cells, Cultured ; Cellular Senescence ; Child ; Dipeptidyl Peptidase 4/genetics ; Dipeptidyl Peptidase 4/metabolism ; Dipeptidyl Peptidase 4/pharmacology ; Humans ; Mesenchymal Stem Cells/metabolism
    Chemical Substances Biomarkers ; DPP4 protein, human (EC 3.4.14.5) ; Dipeptidyl Peptidase 4 (EC 3.4.14.5)
    Language English
    Publishing date 2022-07-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2548671-8
    ISSN 1757-6512 ; 1757-6512
    ISSN (online) 1757-6512
    ISSN 1757-6512
    DOI 10.1186/s13287-022-03026-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients.

    Valerio, Valeria / Hudson, Marie / Wang, Mianbo / Bernatsky, Sasha / Hazel, Elizabeth M / Ward, Brian / Colmegna, Inés

    ACR open rheumatology

    2022  Volume 4, Issue 4, Page(s) 352–362

    Abstract: Objective: Patients with rheumatic disease (RD) have an increased risk of influenza and its complications. Despite inactivated influenza vaccine (IIV) recommendations, IIV uptake in patients with RD is suboptimal, a problem of increasing importance in ... ...

    Abstract Objective: Patients with rheumatic disease (RD) have an increased risk of influenza and its complications. Despite inactivated influenza vaccine (IIV) recommendations, IIV uptake in patients with RD is suboptimal, a problem of increasing importance in the COVID-19 era. We estimated the frequency of IIV hesitancy and associated factors among Canadian patients with RD.
    Methods: A cross-sectional vaccine hesitancy survey was completed by rheumatology clinic patients (November 2019 to January 2020). Patients rated their likelihood of receiving the influenza vaccine (scale of 0-10). We categorized these as follows: likely to refuse (scale of 0-2), uncertain (scale of 3-7), or likely to accept (scale of 8-10). Multivariate logistical regression was used to evaluate factors associated with vaccine hesitancy.
    Results: A total of 282 patients (63.5% of those approached) completed the survey, with 165 (58.5%) being likely to accept, 67 (23.8%) being likely to refuse, and 50 (17.7%) uncertain. Uncertain patients were younger and more likely to be employed than those in the other two groups. No previous influenza vaccination (odds ratio [OR] 36.6, 95% confidence interval [CI] 5.3-252.9), belief that vaccination should not be mandatory (OR 0.1, 95% CI 0.0-0.7), unwillingness to take time off work to be vaccinated (OR 6.8, 95% CI 1.5-30.6), and distrust in pharmaceutical companies (OR 41.0, 95% CI 5.6-301.5) predicted likeliness to refuse. Reluctance to pay for vaccination (OR 2.8, 95% CI 1.1-7.5) and no previous influenza vaccination (OR 18.9, 95% CI 3.3-109.7) predicted uncertainty.
    Conclusion: More than 40% of rheumatology patients are either likely to refuse or uncertain about receiving IIV. This contributes to suboptimal vaccine coverage in this population. Interventions addressing these concerns are needed, particularly in the COVID-19 era.
    Language English
    Publishing date 2022-01-20
    Publishing country United States
    Document type Journal Article
    ISSN 2578-5745
    ISSN (online) 2578-5745
    DOI 10.1002/acr2.11408
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top